Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELUW) Return on Capital Employed (2020 - 2025)

Historic Return on Capital Employed for Celularity (CELUW) over the last 6 years, with Q3 2025 value amounting to 0.93%.

  • Celularity's Return on Capital Employed fell 6500.0% to 0.93% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.93%, marking a year-over-year decrease of 6500.0%. This contributed to the annual value of 0.45% for FY2024, which is 4800.0% up from last year.
  • Celularity's Return on Capital Employed amounted to 0.93% in Q3 2025, which was down 6500.0% from 0.85% recorded in Q2 2025.
  • Celularity's 5-year Return on Capital Employed high stood at 0.07% for Q4 2022, and its period low was 2.31% during Q4 2023.
  • For the 5-year period, Celularity's Return on Capital Employed averaged around 0.66%, with its median value being 0.39% (2023).
  • As far as peak fluctuations go, Celularity's Return on Capital Employed crashed by -22400bps in 2023, and later skyrocketed by 18100bps in 2024.
  • Celularity's Return on Capital Employed (Quarter) stood at 0.27% in 2021, then soared by 73bps to 0.07% in 2022, then tumbled by -3121bps to 2.31% in 2023, then skyrocketed by 78bps to 0.5% in 2024, then plummeted by -88bps to 0.93% in 2025.
  • Its Return on Capital Employed was 0.93% in Q3 2025, compared to 0.85% in Q2 2025 and 0.58% in Q1 2025.